What Happened

Giloy had a long, stable position as a classical Ayurvedic rasayana with substantial domestic Indian use and modest export. Then immunity-positioned supplements expanded sharply worldwide, and giloy — with genuinely documented classical use for immunity and convalescent support — was an obvious beneficiary.

Demand rose quickly. The supply chain that met it was substantially wild collection: a climbing shrub gathered across its native range by dispersed collectors working largely from local common names.

Then came scrutiny. Reports of liver injury associated with giloy-containing products prompted regulatory and scientific attention in India, and species misidentification with Tinospora crispa — a visually similar relative for which hepatotoxicity concerns are documented — was among the explanations proposed by researchers and reviewers.

The structural reading, separate from any individual case: rapid demand growth on a wild-collected botanical with a close look-alike, gathered by common name rather than botanical identification, is a set of conditions that makes species mixing foreseeable. The market's response — a shift toward analytical species verification — addresses exactly that.

Who Buys Giloy Now

The composition of demand changed more than the volume. Three groups remain:

  1. Established Ayurvedic manufacturers, domestic and export, with proper documentation and traditional-use framing. The core of the market.
  2. International supplement brands building Ayurvedic immunity ranges, who now expect species verification as a condition of purchase rather than a premium feature.
  3. Traditional and classical preparation makers, including satva producers, largely domestic and continuous regardless of export trends.

Largely absent: the opportunistic entrants of the peak, who bought on price and volume. That segment's departure took with it much of the demand that was insensitive to authentication.

The Shift From Price to Verification

The important structural change for anyone selling into this market.

During the boom, giloy was bought on availability. Post-scrutiny, the surviving buyers are those whose customers ask questions — regulated-market brands, retailers with quality standards, manufacturers who have been through a compliance review.

For those buyers, a supplier who fingerprints species by HPLC against authentic reference is not offering a premium. They are offering the minimum viable product for a market that now checks.

The practical implication mirrors what happened to garcinia: the cheapest giloy on the market is cheap because it is made for a segment that no longer clears serious retail. If your route to market involves any customer who audits, the low quotation is not a saving.

What Is Driving Demand

Immunity supplements — the volume base

Still the largest application, though at a more sustainable level than the peak. Giloy's advantage is authenticity of heritage: in a category crowded with newly-positioned ingredients, it has genuinely documented classical use spanning millennia.

Ayurvedic range-building

A structural driver. As Ayurvedic product ranges internationalise, giloy is among the recognised names that brands include for credibility — often alongside tulsi, amla and ashwagandha.

Kadha and traditional beverage formats

Genuinely strong in South Asian and diaspora markets, and growing as traditional decoction formats are modernised into shots and sachets. This segment pulls specifically on the water-soluble grade, which is a narrower manufacturing capability than standard powder.

Domestic Indian demand

Very large, continuous, and largely invisible in export statistics. Giloy is a household preparation across much of India, and domestic Ayurvedic manufacturing consumes substantial volume — competing directly with export for the same collected material.

Supply: Wild Collection Versus Cultivation

The supply question that underlies everything above.

Giloy is a climbing shrub growing across its native range, and a substantial share of supply has been wild-collected rather than cultivated. That structure has two consequences:

  1. Authentication is harder. Dispersed collectors working from common names is precisely the structure in which a related species enters the chain — not through deception, but through the ordinary imprecision of vernacular naming.
  2. Traceability is weaker than for a plantation crop, which matters more now that buyers ask.

Cultivation is expanding in response, and cultivated giloy offers a shorter, more controllable chain with better batch consistency. Buyers who require it should ask, and should expect to pay for it — but on this ingredient the premium buys a genuine risk reduction rather than a marketing claim.

Ask collection status per batch and get it on the certificate.

The Regional Picture

India

Origin, the dominant producer, the largest consumer, and where the regulatory scrutiny occurred. Domestic demand is substantial and competes with export.

United States and Europe

Growing Ayurvedic-range demand, with documentation expectations that have risen since the scrutiny period. Immunity claims are constrained in both, so traditional-use framing dominates. General botanical import controls apply — pesticide MRLs, heavy metals, ethylene oxide.

Buyers in both regions should expect their own customers to ask about species verification, and should be able to answer from their product file rather than by asking the supplier retrospectively.

Southeast Asia

Worth a specific note, because T. crispa is itself used traditionally in parts of Southeast Asia under its own names. That is not a problem in itself — it is a different plant with its own traditional context — but it means both species circulate in regional trade, which raises the authentication stakes for material sourced through those channels.

India's Position

India is the native range, the traditional-use home and the manufacturing base, so buying from India is buying at source.

The differentiator within India is the one identified throughout these guides: whether a manufacturer runs HPLC species fingerprinting as a routine release parameter and authenticates at raw-material intake. That capability exists at the serious end of the sector and does not exist everywhere. On this ingredient it is the whole qualification question.

What This Means When You Buy

  1. Buy verification, not just extract. Post-scrutiny, that is what you are actually purchasing.
  2. Treat a very low quotation as a signal. It usually indicates material made for a segment that no longer clears audited retail.
  3. Prefer cultivated or intake-authenticated supply where your market demands assurance.
  4. Ask collection status, and get it on the certificate.
  5. Keep species verification in your product file, not just goods-in records.
  6. Qualify the water-soluble grade separately if beverage formats are in your plan — it is a genuine capability differentiator.
  7. Frame claims on traditional use, which is both defensible and genuinely well supported here.

SV Botanica supplies species-verified giloy extract from India with HPLC fingerprinting against authentic T. cordifolia reference, T. crispa excluded, collection status declared, EU MRL screening and non-ETO declarations per batch. See the giloy extract product specification, the buyer's guide, or applications and formulation.